Cis-platinum and mitomycin-C in treatment of recurrent, metastatic, or residual uterine cervical cancer post radiation.

Abstract

Fifteen patients with recurrent, metastatic, or residual cervical cancer post radiotherapy were treated by combined cis-platinum 40 mg/m2 IV and mitomycin-C 30 mg/m2 IV in day 1, repeated every 4 weeks for 3-5 cycles. The maintained therapy was performed by mitomycin-C 2 mg/day orally for 7 days, every 4 weeks for 6 cycles. Six of 15 patients (40%) showed… (More)

Topics

Cite this paper

@article{Senapad1989CisplatinumAM, title={Cis-platinum and mitomycin-C in treatment of recurrent, metastatic, or residual uterine cervical cancer post radiation.}, author={S Senapad and Somchaya Neungton and C Usavajindawath and S Vijatrasil and V Thaithanaisawanya}, journal={Journal of the Medical Association of Thailand = Chotmaihet thangphaet}, year={1989}, volume={72 7}, pages={382-6} }